References
- Alizadeh-Fanalou S., Babaei M., Hosseini A., Azadi N., Ali Nazarizadeh N., Shojaii A., Borji M., Malekinejad H., Bahreini E.: Effects of Securigera Securidaca seed extract in combination with glibenclamide on antioxidant capacity, fibroblast growth factor 21 and insulin resistance in hyperglycemic rats. J Ethnopharmacol 2020, 248, 112331, doi: 10.1016/j.jep.2019.112331.
- Allard J.S., Perez E.J., Fukui K., Carpenter P., Ingram D.K., de Cabo R.: Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice. Behav Brain Res 2016, 301, 1–9, doi: 10.1016/j.bbr.2015.12.012.
- Amani M., Zolghadrnasab M., Salari A.-A.: NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease. Physiol Behav 2019, 202, 52–61, doi: 10.1016/j.physbeh.2019.01.005.
- Arnold S.E., Arvanitakis Z., Macauley-Rambach S.L., Koenig A.M., Wang H.-Y., Ahima R.S., Craft S., Gandy S., Buettner C., Stoeckel L.E., Holtzman D.M., Nathan D.M.: Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 2018, 14, 168–181, doi: 10.1038/nrneurol.2017.185.
- Baglietto-Vargas D., Shi J., Yaeger D.M., Ager R., LaFerla F.M.: Diabetes and Alzheimer’s disease crosstalk. Neurosci Biobehav Rev 2016, 64, 272–287, doi: 10.1016/j.neubiorev.2016.03.005.
- Baraka A., ElGhotny S.: Study of the effect of inhibiting galanin in Alzheimer’s disease induced in rats. Eur J Pharmacol 2010, 641, 123–127, doi: 10.1016/j.ejphar.2010.05.030.
- Bedse G., Di Domenico F., Serviddio G., Cassano T.: Aberrant insulin signaling in Alzheimer’s disease: current knowledge. Front Neurosci 2015, 9, 204, doi: 10.3389/fnins.2015.00204.
- Biessels G.J., Strachan M.W.J., Visseren F.L.J., Kappelle L.J., Whitmer R.A.: Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2014, 2, 246–255, doi: 10.1016/S2213-8587(13)70088-3.
- Brewster A.L., Lugo J.N., Patil V.V., Lee W.L., Qian Y., Vanegas F., Anderson A.E.: Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage. PLoS One 2013, 8, e57808, doi: 10.1371/journal.pone.0057808.
- Brownlee M.: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54, 1615–1625, doi: 10.2337/diabetes.54.6.1615.
- Chen F., Dong R.R., Zhong K.L., Ghosh A., Tang S.S., Long Y., Hu M., Miao M.X., Liao J.M., Sun H.B., Kong L.Y., Hong H.: Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db/db mice. Neuropharmacology 2016, 101, 123–136, doi: 10.1016/ j.neuropharm.2015.07.023.
- Chornenkyy Y., Wang W.-X., Wei A., Nelson P.T.: Alzheimer’s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline. Brain Pathol 2019, 29, 3–17, doi: 10.1111/bpa.12655.
- Chong Z.Z., Shang Y.C., Zhang L., Wang S., Maiese K.: Mammalian target of rapamycin: hitting the bull’s-eye for neurological disorders. Oxid Med Cell Longev 2010, 3, 374–391, doi: 10.4161/oxim.3.6.14787.
- Correia S.C., Santos R.X., Carvalho C., Cardoso S., Candeias E., Santos M.S., Oliviera C.R., Moreira P.I.: Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation. Brain Res 2012, 1441, 64–78, doi: 10.1016/j.brainres.2011.12.063.
- Costa A., Peppe A., Carlesimo G.A., Zabberoni S., Scalici F., Caltagirone C., Angelucci F.: Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson’s disease patients with mild cognitive impairment. Front Behav Neurosci 2015, 9, 253, doi: 10.3389/fnbeh.2015.00253.
- Dou J.-T., Chen M., Dufour F., Alkon D.L., Zhao W.-Q.: Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem 2015, 12, 646–655, doi: 10.1101/lm.88005.
- El Batsh M.M., El Batch M.M., Shafik N.M., Younos I.H.: Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats. Eur J Pharmacol 2015, 769, 297–305, doi: 10.1016/j.ejphar.2015.11.033.
- Fangfang Z., Yangjun L., Binbin Y., Zhiping H.: Neuroprotective potential of glibenclamide is mediated by antioxidant and anti-apoptotic pathways in intracerebral hemorrhage. Brain Res Bull 2018, 142, 18–24, doi: 10.1016/j.brainresbull.2018.06.006.
- Faul F., Erdfelder E., Buchner A., Lang A.-G.: Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 2009, 41, 1149–1160, doi: 10.3758/BRM.41.4.1149.
- Gainey S.J., Kwakwa K.A., Bray J.K., Pillote M.M., Tir V.L., Towers A.E., Freund G.G.: Short-term high-fat diet (HFD) induced anxiety-like behaviors and cognitive impairment are improved with treatment by glyburide. Front Behav Neurosci 2016, 10, 156, doi: 10.3389/fnbeh.2016.00156.
- Hsu C.-C., Wahlqvist M.L., Lee M.-S., Tsai H.-N.: Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 2011, 24, 485–493, doi: 10.3233/JAD-2011-101524.
- Jain V., Baitharu I., Prasad D., Ilavazhagan G.: Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation. PLoS One 2013, 8, e62235, doi: 10.1371/journal.pone.0062235.
- Khanfar M.A., AbuKhader M.M., Alqtaishat S., Taha M.O.: Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone. J Mol Graph Model 2013, 42, 39–49, doi: 10.1016/j.jmgm.2013.02.009.
- Kho R.A., Choi B.Y., Lee S.H., Hong D.K.,Lee S.H., Jeong H.J., Park K.-H., Song H.K., Choi H.C., Suh S.W.: Effects of Protocatechuic Acid (PCA) on Global Cerebral Ischemia–Induced Hippocampal Neuronal Death. Int J Mol Sci 2018, 19, 1420, doi: 10.3390/ijms19051420.
- Kobayashi K., Takemori K., Sakamoto A.: Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Brain Res 2007, 1185, 1–7, doi: 10.1016/j.brainres.2007.09.011.
- Kujawska M., Jodynis-Liebert J.: Polyphenols in Parkinson’s disease: A Systematic Review of In Vivo Studies. Nutrients 2018, 10, 642, doi: 10.3390/nu10050642.
- Li J., Deng J., Sheng W., Zuo Z.: Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 2012, 101, 564–574, doi: 10.1016/j.pbb.2012.03.002.
- Lu B., Nagappan G., Lu Y.: BDNF and synaptic plasticity, cognitive function, and dysfunction. In: Handbook of Experimtental Pharmacology, volume 220, edited by G.R. Lewin, B.D. Carter Springer, Berlin, 2014, pp. 223–250, doi: 10.1007/978-3-642-45106-5_9.
- Łuc M., Woźniak M., Helemejko M., Rymaszewska J.: Tackling Alzheimer’s disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents. Life Sci 2019, 231, 116483, doi: 10.1016/j.lfs.2019.05.039.
- Mittal K., Katare D.P.: Shared links between type 2 diabetes mellitus and Alzheimer’s disease: A review. Diabetes Metab Syndr 2016, 10 (2 Suppl 1), S144–S149, doi: 10.1016/j.dsx.2016.01.021.
- Moran C., Phan T.G., Chen J., Blizzard L., Beare R., Venn A., Münch G., Wood A.G., Forbes J., Greenaway T.M., Pearson S, Srikanth V.: Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013, 36, 4036–4042, doi: 10.2337/dc13-0143.
- Ortega F.J., Jolkkonen J., Mahy N., Rodríguez M.J.: Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2013, 33, 356–364, doi: 10.1038/jcbfm.2012.166.
- Osborne C., West E., Nolan W., McHale-Owen H., Williams A., Bate C.: Glimepiride protects neurons against amyloid-β-induced synapse damage. Neuropharmacology 2016, 101, 225–236, doi: 10.1016/j.neuropharm.2015.09.030.
- Patil S.P., Jain P.D., Ghumatkar P.J., Tambe R., Sathaye S.: Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice. Neuroscience 2014, 277, 747–754, doi: 10.1016/j.neuroscience.2014.07.046.
- Pintana H., Apaijai N., Pratchayasakul W., Chattipakorn N., Chattipakorn S.C.: Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sci 2012, 91, 409–414, doi: 10.1016/j.lfs.2012.08.017.
- Rafique M.B., Cameron S.D., Khan Q., Biliciler S., Zubair S.: Anesthesia for children with mitochondrial disorders: a national survey and review. J Anesth 2013, 27, 186–191, doi: 10.1007/s00540-012-1488-1.
- Roberts R.O., Knopman D.S., Przybelski S.A., Mielke M.M., Kantarci K., Preboske G.M., Senjem M.L., Pankratz V.S., Geda Y.E., Boeve B.F., Ivnik R.J., Rocca W.A., Petersen R.C., Jack C.R. Jr.: Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 2014, 82, 1132–1141, doi: 10.1212/WNL.0000000000000269.
- Roriz-Filho J.S., Sá-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L.F., Moriguti J.C., Roriz-Cruz M.: (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792, 432–443, doi: 10.1016/j.bbadis.2008.12.003.
- Stokum J.A., Keledjian K., Hayman E., Karimy J.K., Pampori A., Imran Z., Woo S.K., Gerzanich V., Simard J.M.: Glibenclamide pretreatment protects against chronic memory dysfunction and glial activation in rat cranial blast traumatic brain injury. Behav Brain Res 2017, 333, 43–53, doi: 10.1016/j.bbr.2017.06.038.
- Wolfer D.P., Madani R., Valenti P., Lipp H.-P.: Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav 2001, 73, 745–753, doi: 10.1016/S0031-9384(01)00531-5.
- Xiao H., Liu B., Chen Y., Zhang J.: Learning, memory and synaptic plasticity in hippocampus in rats exposed to sevoflurane. Int J Dev Neurosci 2016, 48, 38–49, doi: 10.1016/j.ijdevneu. 2015.11.001.
- Yin X., Zhang X., Lv C., Li C., Yu Y., W., Han F.: Protocatechuic acid ameliorates neurocognitive functions impairment induced by chronic intermittent hypoxia. Sci Rep 2015, 5, 14507, doi: 10.1038/srep14507.
- Zhang D.-X., Jiang S., Yu L.-N., Zhang F.-J., Zhuang Q., Yan M.: The effect of sevoflurane on the cognitive function of rats and its association with the inhibition of synaptic transmission. Int J Clin Exp Med 2015, 8, 20853–20860.
- Zhang T., Gu J., Wu L., Li N., Sun Y., Yu P., Wang Y., Zhang G., Zhang Z.: Neuroprotective and axonal outgrowth-promoting effects of tetramethyl pyrazine nitrone in chronic cerebral hypoperfusion rats and primary hippocampal neurons exposed to hypoxia. Neuropharmacology 2017, 118, 137–147, doi: 10.1016/j.neuropharm.2017.03.022.
- Zheng Y., Ley S.H., Hu F.B.: Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018, 14, 88–98, doi: 10.1038/nrendo.2017.151.
- Zou Y., Zhou C., Xu H., Yu J., Ye P., Zhang H., Chen S., Zhao J., Le S., Cui J., Jiang L., Wu J., Xia J.: Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression. Life Sci 2020, 241, 117141, doi: 10.1016/j.lfs.2019.117141.